Park Medi World Limited IPO
Hospital · DRHP 29 Mar 2025 · listed 17 Dec 2025
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹162.00
- band ₹154.00 to ₹162.00
- Issue size
- ₹920.0 cr
- fresh ₹770 cr · OFS ₹150 cr
- Lot
- 92 shares
- ₹14,904 at the top of the band
- Subscription window
- 10 Dec to 12 Dec
- 2025
- Listing
- 17 Dec 2025
- NSE
- Subscribed
- 6.5x
- retail 2.4x
About the Park Medi World IPO
Park Medi World Limited raised ₹920 crore through a mainboard IPO on NSE and BSE: a fresh issue of ₹770 crore and an offer for sale of ₹150 crore. The fresh issue goes to the company; the offer for sale goes to the shareholders selling.
Bidding ran Wed 10 Dec to Fri 12 Dec, at an issue price of ₹162 a share, in lots of 92 shares. The shares listed on 17 Dec 2025.
The book-running lead managers are Nuvama Wealth Management Limited, CLSA India Private Limited and DAM Capital Advisors Limited. The registrar, which handles allotment, is KFin Technologies Limited.
The issue was subscribed 6.51 times overall, with the retail portion at 2.4 times, as the exchange's bid book showed.
The draft offer document was filed on 29 Mar 2025.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Park Medi World IPO: questions answered
When was the Park Medi World IPO open, and what were the price band and lot size?
Bidding ran Wed 10 Dec to Fri 12 Dec. The issue price is ₹162 a share. One lot is 92 shares, ₹14,904 at the upper end of the band.
When did the Park Medi World IPO list?
The shares listed on 17 Dec 2025 on NSE and BSE.
How do I check the Park Medi World IPO allotment status?
Allotment is finalised by the registrar, KFin Technologies Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Park Medi World IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Park Medi World IPO?
The book-running lead managers are Nuvama Wealth Management Limited, CLSA India Private Limited and DAM Capital Advisors Limited. The registrar, which handles applications and allotment, is KFin Technologies Limited.
How many times was the Park Medi World IPO subscribed?
6.51 times overall, as the exchange's bid book last showed: qualified institutions 9.18 times, non-institutional investors 8.35 times and retail 2.4 times.
Is the Park Medi World IPO a fresh issue or an offer for sale?
A fresh issue of ₹770 crore, which goes to the company, and an offer for sale of ₹150 crore, which goes to the shareholders selling (16% of the issue).
What is the Park Medi World IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Where the money went
The monitoring agency's report for the quarter to 30 Jun 2026: each object in the offer document and how much of it had been used by then.
| Object | Proposed, ₹ crore | Used, ₹ crore |
|---|---|---|
| Repayment/ prepayment, in full or in part, of outstanding borrowings availed by the Company and its Subsidiaries | 605.0 | 195.2 |
| Total | 7,700.0 | 7,051.7 |
Park Medi World IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.
The figures on this page are the company's own, taken from its filings with the exchanges and SEBI, and every number links to the document and page it came from. They are reproduced as stated, not verified independently, and they are not forecasts by newboard.in. Nothing here is investment advice, a research report or a recommendation. newboard.in is not a SEBI-registered research analyst or investment adviser.